Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Apply
CAR T Cell Therapy
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step